New England Capital Financial Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10
Closed -$484 436
2025
Q2
$484 Hold
10
﹤0.01% 385
2025
Q1
$555 Hold
10
﹤0.01% 354
2024
Q4
$483 Hold
10
﹤0.01% 378
2024
Q3
$577 Hold
10
﹤0.01% 361
2024
Q2
$486 Hold
10
﹤0.01% 360
2024
Q1
$486 Hold
10
﹤0.01% 367
2023
Q4
$498 Hold
10
﹤0.01% 365
2023
Q3
$537 Hold
10
﹤0.01% 356
2023
Q2
$539 Hold
10
﹤0.01% 355
2023
Q1
$545 Hold
10
﹤0.01% 396
2022
Q4
$491 Buy
+10
New +$439 ﹤0.01% 399

Other funds holding SNY

New England Capital Financial Advisors's SNY Position: Q3 2025 in Review

New England Capital Financial Advisors sold out of Sanofi (SNY) in Q3 2025, closing a stake of 10 shares — an estimated $484 sold.

New England Capital Financial Advisors first reported a position in SNY in Q4 2022 and held it in 11 quarters. The position peaked at $577 in Q3 2024. 711 funds tracked by Wall St. Rank hold SNY as of Q3 2025.

  • New England Capital Financial Advisors reported no remaining Sanofi position as of Q3 2025 after selling out during the quarter.
  • New England Capital Financial Advisors sold 10 Sanofi shares in Q3 2025, an estimated $484.
  • New England Capital Financial Advisors first reported a position in Sanofi in Q4 2022 and held it in 11 quarters.
  • New England Capital Financial Advisors's Sanofi position peaked at $577 in Q3 2024.
  • 711 funds tracked by Wall St. Rank held Sanofi as of Q3 2025.

Based on New England Capital Financial Advisors's 13F filing for Q3 2025, filed 22 Oct 2025.